The Commonwealth Fund Task Force on Payment and Delivery System Reform identified policy interventions for making the U.S. health care delivery system more affordable, equitable and higher quality.
The Advisory Group is providing strategic insights on how to develop continuity across AcademyHealth’s diversity, equity and inclusion activities. Members represent a variety of lived experiences, racial/ethnic identities, gender identities, geographies, organizational settings, areas of professional expertise, and career stages.
In a webinar for the Research Community on Low-Value-Care, experts shared three key considerations for designing an equitable, high-value health care system. They emphasized the need to ensure equitable care is being delivered by a diverse workforce with an understanding of how to use data to improve interventions to advance equity.
After several years of working to diversify the health services research (HSR) workforce and build a community through networking and mentoring, we want and need to do much more to accelerate systemic change.
Voices of a New Paradigm: The AcademyHealth Paradigm Project is profiling leaders whose work helps point Health Services Research in a new direction. Some are new to HSR, others may just be new to us – leaders in other fields whose work is inspiring or applicable. All are challenging the limits of the current paradigm in ways that help make HSR more effective and have greater impact.
Climate change and the COVID-19 pandemic both have profound negative impacts on our health, wellbeing, and way of life, and exacerbate health inequities. Both threats also call for collaboration on an unprecedented scale and speed.
In the second of a two-part series, AcademyHealth President and CEO Lisa Simpson highlights three strategies aimed at addressing the wide variation in the degree of disruption, disproportionate impact, and decision-making capacity across states and localities.
In the first of a two-part series, AcademyHealth President and CEO Lisa Simpson reflects on four challenges that need immediate attention to repair the fractured and failed health system.
A recent discussion, focused on ensuring sufficient investment and interest in vaccine development for the next infectious threat, brought to light the incredible complexity involved in developing, manufacturing and distributing a vaccine on a massive scale in an equitable way.
Summarizing an expert discussion at an August 2020 virtual meeting, this brief examines the COVID-19 vaccine development experience and reviews existing research on vaccine development, manufacturing, and distribution, including financing mechanisms to help ensure its accessibility, as well as policies to promote equity.
